GP1BB

glycoprotein Ib (platelet), beta polypeptide

GP1BB; glycoprotein Ib (platelet), beta polypeptide; platelet glycoprotein Ib beta chain; CD42c; Antigen CD42b beta; CD_antigen=CD42c; Flags: Precursor; Glycoprotein Ib (platelet) beta polypeptide; Glycoprotein Ib beta polypeptide; GP Ib beta; GP Ib beta subunit; GP1bbeta; GPIb beta; Nuclear localization signal deleted in velocardiofacial syndrome; Platelet glycoprotein Ib beta polypeptide; GPIb-beta; GP-Ib beta; antigen CD42b-beta; BS; GPIBB; BDPLT1;

PAFAH1B2

platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)

PAFAH1B2; platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa); platelet-activating factor acetylhydrolase IB subunit beta; PAF acetylhydrolase 30 kDa subunit; PAF AH 30 kDa subunit; PAF AH beta subunit; PAF AH subunit beta; PAFAH 30 kDa subunit; PAFAH beta subunit; PAFAH subunit beta; PAFAH1B2 protein; PAFAHB; Platelet activating factor acetylhydrolase IB beta subunit; Platelet activating factor acetylhydrolase IB subunit beta; Platelet activating factor acetylhydrolase isoform Ib beta subunit; PAF-AH subunit beta; PAF-AH 30 kDa subunit; platelet-activating factor acetylhydrolase, isoform Ib, subunit 2 (30kDa); platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa; platelet-activating factor acetylhydrolase, isoform Ib, beta subunit (30kD);

Pdgfa

platelet-derived growth factor alpha polypeptide

PDGFA; platelet-derived growth factor alpha polypeptide; PDGF1; PDGF-A; PDGF A-chain; platelet-derived growth factor alpha chain; Platelet-derived growth factor subunit A; PDGF subunit A; Platelet-derived growth factor A chain; PDGF-1; OTTHUMP00000199955; OTTHUMP00000199956; platelet-derived growth factor alpha isoform 2 preproprotein;

PDGFB

platelet-derived growth factor beta polypeptide

PDGFB; platelet-derived growth factor beta polypeptide; SIS; SSV; IBGC5; PDGF2; c-sis; PDGF-2; platelet-derived growth factor subunit B; becaplermin; PDGF, B chain; PDGF subunit B; proto-oncogene c-Sis; platelet-derived growth factor 2; platelet-derived growth factor B chain; platelet-derived growth factor, beta polypeptide (oncogene SIS); platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog);

PDGFC

platelet derived growth factor C

PDGFC; platelet derived growth factor C; platelet-derived growth factor C; fallotein; SCDGF; PDGF-C; VEGF-E; spinal cord-derived growth factor; secretory growth factor-like protein; AI647969; 1110064L01Rik;

PDGFD

platelet derived growth factor D

PDGFD; platelet derived growth factor D; platelet-derived growth factor D; IEGF; MSTP036; SCDGF B; spinal cord derived growth factor B; PDGF-D; iris-expressed growth factor; spinal cord-derived growth factor B; spinal cord-derived growth factor-B; SCDGFB; SCDGF-B;

PDGFRA

platelet-derived growth factor receptor, alpha polypeptide

PDGFRA; platelet-derived growth factor receptor, alpha polypeptide; platelet-derived growth factor receptor alpha; CD140a; PDGFR2; PDGFR-alpha; PDGF-R-alpha; CD140a antigen; PDGFRA/BCR fusion; CD140 antigen-like family member A; platelet-derived growth factor receptor 2; alpha-type platelet-derived growth factor receptor; rearranged-in-hypereosinophilia-platelet derived growth factor receptor alpha fusion protein; CD140A; PDGFR-2; RHEPDGFRA; MGC74795;

PDGFRB

platelet derived growth factor receptor, beta polypeptide

PDGFRB; platelet derived growth factor receptor, beta polypeptide; beta-type platelet-derived growth factor receptor; CD140B; Beta platelet derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD 140B; CD140 antigen-like family member B; CD140b antigen; JTK12; OTTHUMP00000160528; PDGF R beta; PDGF-R-beta; PDGFR; PDGFR1; PDGFRB; PGFRB_HUMAN; Platelet derived growth factor receptor beta; Platelet derived growth factor receptor beta polypeptide; PDGF-R-beta; PDGF beta chain; OTTMUSP00000015854; OTTMUSP00000015855; CD140 antigen-like family member B; platelet-derived growth factor receptor beta variant 1; Pdgfr; CD140b; AI528809;

PECAM1

platelet/endothelial cell adhesion molecule 1

PECAM1; platelet/endothelial cell adhesion molecule 1; CD31; PECA1; GPIIA; PECAM-1; endoCAM; CD31/EndoCAM; platelet endothelial cell adhesion molecule; CD31 antigen; Pecam;

PF4

platelet factor 4

PF4; platelet factor 4; PF-4; CXCL4; SCYB4; iroplact; oncostatin-A; C-X-C motif chemokine 4; chemokine (C-X-C motif) ligand 4;

PLA2G2A

phospholipase A2, group IIA (platelets, synovial fluid)

PLA2G2A; phospholipase A2, group IIA (platelets, synovial fluid); phospholipase A2, membrane associated; GIIC sPLA2; enhancing factor; modifier of Min1; group IIA phospholipase A2; secretory group II phospholipase A2; phosphatidylcholine 2-acylhydrolase 2A; non-pancreatic secreted type II phospholipase A2; EF; Mom1; Pla2; sPLA2; sPla2-IIA;

PLA2G7

phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)

PLA2G7; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); platelet-activating factor acetylhydrolase; LDL PLA2; PAFAH; LDL-PLA(2); gVIIA-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; group-VIIA phospholipase A2; LDL-associated phospholipase A2; lipoprotein-associated phospholipase A2; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; PAFAD; LP-PLA2; LDL-PLA2;

PLAT

plasminogen activator, tissue

PLAT; plasminogen activator, tissue; TPA; T-PA; DKFZp686I03148; tissue-type plasminogen activator; alteplase; reteplase; OTTHUMP00000225783; OTTHUMP00000225784; OTTHUMP00000225785; OTTHUMP00000225786; OTTHUMP00000225787; OTTHUMP00000225788; t-plasminogen activator; plasminogen activator, tissue type; tissue plasminogen activator (t-PA);

PPBP

pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)

Ppbp; PPBP; pro-platelet basic protein (chemokine (C-X-C motif) ligand 7); platelet basic protein; neutrophil activating peptide-2; chemokine (C-X-C motif) ligand 7; Cxcl7; Nap-2;

ITGA2B

integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)

ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); GT; GTA; CD41; GP2B; HPA3; CD41B; GPIIb; BDPLT2; BDPLT16; integrin alpha-IIb; GPalpha IIb; platelet-specific antigen BAK; platelet membrane glycoprotein IIb; platelet fibrinogen receptor, alpha subunit;

GP1BA

glycoprotein Ib (platelet), alpha polypeptide

BSS; GP1B; CD42B; mgC34595; CD42b-alpha; GP1BA; platelet glycoprotein Ib alpha chain; GPIbA GP-Ib alpha antigen CD42b-alpha platelet membrane glycoprotein 1b-alpha subunit;

GP9

glycoprotein IX (platelet)

GPIX; CD42a; GP9 platelet glycoprotein IX; GP-IX; glycoprotein 9; OTTHUMP00000217111;

ITGB3

integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)

GT; CD61; GP3A; BDPLT2; GPIIIa; integrin beta-3; platelet glycoprotein IIIa; platelet membrane glycoprotein IIIa; CD41; CD41b; GP 2B; GP IIb; GTA; HPA3; Integrin alpha 2b; ITGA2B; ITGB3; Tadocizumab; 339086-80-5;

PAFAH1B1

platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)

PAFAH1B1; platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa); MDCR, MDS, Miller Dieker syndrome chromosome region , platelet activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD) , platelet activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa , platelet activating factor acetylhydrolase, isoform Ib, subunit 1 (45kDa); platelet-activating factor acetylhydrolase IB subunit alpha; LIS1; PAFAH; LIS-1; PAFAH alpha; PAF-AH alpha; PAF-AH 45 kDa subunit; lissencephaly 1 protein; lissencephaly-1 protein; PAF acetylhydrolase 45 kDa subunit; platelet-activating factor acetylhydrolase, isoform Ib, subunit 1 (45kDa); platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD); MDS; LIS2; MDCR;

PAFAH1B3

platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa)

PAFAH1B3; platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa); platelet activating factor acetylhydrolase, isoform Ib, gamma subunit (29kD) , platelet activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa , platelet activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa); platelet-activating factor acetylhydrolase IB subunit gamma; PAF AH1b alpha 1 subunit; PA1B3_HUMAN; PAF acetylhydrolase 29 kDa subunit; PAF AH 29 kDa subunit; PAF AH subunit gamma; PAF-AH 29 kDa subunit; PAF-AH subunit gamma; PAFAH subunit gamma; PAFAHG; Platelet activating factor acetylhydrolase IB subunit gamma; Platelet activating factor acetylhydrolase isoform Ib gamma subunit (29kD); Platelet activating factor acetylhydrolase isoform Ib gamma subunit 29kDa; Platelet activating factor acetylhydrolase isoform Ib gamma subunit; PAF-AH1b alpha 1 subunit; platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa;

TBXAS1

thromboxane A synthase 1 (platelet)

TBXAS1; thromboxane A synthase 1 (platelet); thromboxane A synthase 1 (platelet, cytochrome P450, subfamily V); thromboxane-A synthase; CYP5; CYP5A1; cytochrome P450; family 5; subfamily A; polypeptide 1; THAS; TS; TXAS; TXS; Cytochrome P450 5A1; FLJ52771; GHOSAL; THAS_HUMAN; Thromboxane A synthase 1 platelet cytochrome P450 subfamily V; TXA synthase; OTTHUMP00000211927; OTTHUMP00000211928; OTTHUMP00000211929; OTTHUMP00000211930; OTTHUMP00000211931; platelet, cytochrome P450, subfamily V; cytochrome P450, family 5, subfamily A, polypeptide 1; thromboxane; BDPLT14;

PF4V1

platelet factor 4 variant 1

PF4V1; platelet factor 4 variant 1; platelet factor 4 variant; CXCL4L1; CXCL4V1; SCYB4V1; CXC motif chemokine 4 variant; PF4alt; PF4var1; C-X-C motif chemokine 4; platelet factor 4, variant 1 (PF4-like); PF4A; PF4-ALT;

GP5

glycoprotein V (platelet)

GP5; glycoprotein V (platelet); GPV; CD42d; platelet glycoprotein V; glycoprotein 5;

PAFAH2

platelet-activating factor acetylhydrolase 2, 40kDa

PAFAH2; platelet-activating factor acetylhydrolase 2, 40kDa; platelet activating factor acetylhydrolase 2 (40kD); platelet-activating factor acetylhydrolase 2, cytoplasmic; HSD PLA2; EC 3.1.1.47; HSDPLA2; Platelet activating factor acetylhydrolase 2; Serine dependent phospholipase A2; SD-PLA2; serine-dependent phospholipase A2; HSD-PLA2;

PFKP

phosphofructokinase, platelet

PFKP; phosphofructokinase, platelet; 6-phosphofructokinase type C; PFK C; PFKF; Phosphofructokinase; platelet type; phosphohexokinase; phosphofructokinase 1; phosphofructo-1-kinase isozyme C; Phosphofructokinase, platelet type; 6-phosphofructokinase, plat;

GP6

glycoprotein VI (platelet)

GP6; glycoprotein VI (platelet); platelet glycoprotein VI; GPVI; Glycoprotein VI; GPIV; MGC138168; Platelet collagen receptor; Platelet glycoprotein VI precursor; glycoprotein 6; BDPLT11;

PDGFRL

platelet-derived growth factor receptor-like

PDGFRL; platelet-derived growth factor receptor-like; platelet-derived growth factor receptor-like protein; PRLTS; PDGFR-like protein; PDGF receptor beta-like tumor suppressor; platelet-derived growth factor-beta-like tumor suppressor; PDGRL;

UCMA

upper zone of growth plate and cartilage matrix associated

UCMA; upper zone of growth plate and cartilage matrix associated; C10orf49, chromosome 10 open reading frame 49; unique cartilage matrix-associated protein; AW121955; C10orf49; Grp; 1110017I16Rik; Gla rich protein; Gla-rich protein; OTTMUSP00000011599; RP23-272I15.1; Ucma-C; UCMA_HUMAN; Unique cartilage matrix associated protein; Unique cartilage matrix-associated protein C-terminal fragment;

PEAR1

platelet endothelial aggregation receptor 1

PEAR1; platelet endothelial aggregation receptor 1; MEGF12, multiple EGF like domains 12; FLJ00193; JEDI; hPEAR1; multiple EGF-like-domains 12; multiple EGF-like domains protein 12; multiple epidermal growth factor-like domains protein 12; MEGF12;

PTAFR

Platelet-Activating Factor Receptor

PTAFR; platelet-activating factor receptor; PAFR; PAF-R; OTTHUMP00000004040; OTTHUMP00000004041; PAF Receptor;

PDGFRα

platelet-derived growth factor receptor, alpha polypeptide

CD140A; PDGFR2; PDGFR-2; RHEPDGFRA;

CXCL7

pro-platelet basic protein

TGB; LDGF; MDGF; TGB1; CTAP3; Cxcl7; NAP-2; Scyb7; b-TG1; LA-PF4; THBGB1; CTAPIII; beta-TG; AI854500; NAP-2-L1; 2400003M24Rik;

Nicotiana tabacum Specific Expression Platform

Creative BioMart's recombinant proteins under Animal Component-Free Process (ACFP) are expressed in cell lines using dedicated animal-free raw materials and labware. Production and purification procedures use equipment and media that are confirmed animal-free. Every stage of the manufacturing proce...

Rice Endosperm Specific Expression Platform

Creative BioMart's recombinant proteins under Animal Component-Free Process (ACFP) are expressed in cell lines using dedicated animal-free raw materials and labware. Production and purification procedures use equipment and media that are confirmed animal-free. Every stage of the manufacturing proce...

Electron Transfer Quenching Platform

Quenching refers to any process which decreases the fluorescence intensity of a given substance. It refers to reduction of fluorescence intensity by another molecule, one that causes some of the excited fluorophore to return to their ground states without emitting photons. Quenching is used in optod...

Cell-free Display Platform

Many types of cell-free approaches have been developed for directed evolution in which the presence of cells is not required. For example, ribosome display, mRNA display, aptamers, in vitro compartmentalization (IVC), cis-activity based (CIS) display and covalent antibody display (CAD) are, among ot...

<em>Escherichia coli</em> Display Platform

E. coli, as a type of Gram-negative bacteria, is the most widely used cell display system in directed evolution. Since the first use for recombinant protein production, this system has been employed to display various proteins/peptides. With the power of high-throughput technologies, such as magneti...

Phage Display Platform

Phage display, first described by George P. Smith in 1985, is a powerful laboratory technique applied in directed evolution. Since the first report on phage display and selection of human antibodies in 1991, this technology is now widely used. Today, antibody libraries containing millions of antibod...

Special Cell-based Display Platform

Besides commonly used hosts, such as E. coli, yeast and phage, there are other cells that can also be used for protein display, although not widely employed. Gram-positive bacteria display method, for example, is playing a special role in directed evolution. Because of the rigid structure of their c...

Yeast Display Platform

Yeast display, first published by Professor K. Dane Wittrup in 1997, is a protein engineering technique that uses the expression of recombinant proteins incorporated into the cell wall of yeast for isolating and engineering antibodies. Saccharomyces cerevisiae, a species of yeast, is one of the most...

Membrane Protein Platform: Nanodisc

Membrane proteins play an essential role in exchanging material, information, and energy between cells and the external environment and are one of the current research hotspots. However, since membrane proteins have hydrophobic moieties and are easily polymerized in vitro, it is necessary to find a ...

Virus-Like Particles (VLPs) Technology Platform

Virus-like particles (VLPs) are large particles assembled from one or several structural proteins of multiple viruses. VLPs are missing viral nucleic acids and cannot replicate autonomously. Depending on their origin and structural characteristics, VLPs can be classified into several types, includin...

Detergent Micelle Platform

Proteins are inserted in lipid bilayers through hydrophobic interactions between lipid tails and hydrophobic protein structural domains. These integral membrane proteins are insoluble in aqueous solution and are aggregated. However, they can be soluble in descaling agents, which form micelles simila...

Nanodisc Technology Platform

Nanodiscs are discoidal lipid bilayers 8-16 nm in diameter stabilized and solubilized in aqueous solution by two encircling amphipathic helical protein ribbons (called membrane scaffolding proteins). The size of the Nanodisc is determined by the length of the membrane scaffolding proteins and the ra...

Liposome Technology Platform

The traditional method of extracting membrane proteins is to use a detergent to separate the target membrane protein from all other components. Various reagents can disrupt the membrane, but the membrane that these reagents disrupt also removes the membrane surrounding the protein, which may affect ...

GMP Stable Cell Line Development Platform

The construction of efficient and stable cell lines is crucial for developing CMC for macromolecule drugs and is also a critical factor in obtaining high-quality proteins and antibodies. Creative Biomart has a complete GMP cell line construction platform and provides comprehensive and professional G...

Part of Proprietary Technology Platforms of Creative BioMart

With innovative thoughts and fast growing technologies,Creative BioMart experts have developed many efficient and advanced proprietarytechnical platforms that have gained numerous praises. As a biotech manufacture, its goal is to mutually benefit research communities, institutions and others. Here...